drugset / Trial / NCT05212025
Adavosertib and Gemcitabine in Advanced Pancreatic
Phase 2
Withdrawn
James Cleary, MD, PhD
AstraZeneca · collabLustgarten Foundation · collabStand Up To Cancer · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to test the safety and effectiveness of combining Adavosertib and Gemcitabine in patients with pancreatic cancer. The names of the study drugs involved in this study are: * Adavosertib * Gemcitabine
Timeline
- Start
- 2022-06
- Primary completion
- 2023-06-01
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adavosertib | Small molecule | — | Oral |
| Subject | Gemcitabine | Small molecule | — | Intravenous |